We are live on
!
Find out more
iShares Biotechnology ETF
306 hedge funds and large institutions have $4.42B invested in iShares Biotechnology ETF in 2014 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 81 increasing their positions, 117 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
46% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 41
6% more funds holding
Funds holding: 288 → 306 (+18)
3% less capital invested
Capital invested by funds: $4.56B → $4.42B (-$146M)
30% less funds holding in top 10
Funds holding in top 10: 20 → 14 (-6)
31% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 117
35% less call options, than puts
Call options by funds: $439M | Put options by funds: $675M
Holders
306
Holders Change
+18
Holders Change %
+6.25%
% of All Funds
8.8%
Holding in Top 10
14
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-30%
% of All Funds
0.4%
New
60
Increased
81
Reduced
117
Closed
41
Calls
$439M
Puts
$675M
Net Calls
-$236M
Net Calls Change
-$115M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$81.2M |
| 2 |
Morgan Stanley
New York
|
+$66.5M |
| 3 |
SG Americas Securities
New York
|
+$51.4M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21M |
| 5 |
HI
Honeywell International
Charlotte,
North Carolina
|
+$17.7M |
Top Sellers
| 1 |
Citigroup
New York
|
-$231M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$217M |
| 3 |
Barclays
London,
United Kingdom
|
-$69.1M |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$68.7M |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
-$52.7M |
